BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 11469004)

  • 1. [Study of heart failure. Is phytotherapy effective?].
    MMW Fortschr Med; 2001 Jun; 143(25):59. PubMed ID: 11469004
    [No Abstract]   [Full Text] [Related]  

  • 2. [Even in advanced heart failure, hawthorn improves physical capacity].
    MMW Fortschr Med; 2003 Jan; 145(1-2):52. PubMed ID: 12638441
    [No Abstract]   [Full Text] [Related]  

  • 3. Digitalis therapy for patients in clinical heart failure.
    Rahimtoola SH
    Circulation; 2004 Jun; 109(24):2942-6. PubMed ID: 15210610
    [No Abstract]   [Full Text] [Related]  

  • 4. [Challenge for the general practitioner. Sufficient therapy for heart failure].
    Füessl HS
    MMW Fortschr Med; 2000 Nov; 142(46):4-8. PubMed ID: 11132311
    [No Abstract]   [Full Text] [Related]  

  • 5. [Efficacy and problems of cardiotonic agents viewed from physiopathology of chronic congestive heart failure].
    Asanoi H; Inoue H
    Nihon Naika Gakkai Zasshi; 1995 Sep; 84(9):1465-9. PubMed ID: 8537751
    [No Abstract]   [Full Text] [Related]  

  • 6. Intravenous amrinone for congestive heart failure.
    Med Lett Drugs Ther; 1984 Nov; 26(675):104-5. PubMed ID: 6390109
    [No Abstract]   [Full Text] [Related]  

  • 7. Present status of various inotropic agents in heart failure.
    Mittal SR; Maheshwari N
    J Assoc Physicians India; 2001 Nov; 49():1095-9. PubMed ID: 11868865
    [No Abstract]   [Full Text] [Related]  

  • 8. [Decreased cardiac output in the elderly. Cardiotonic effect of hawthorn].
    MMW Fortschr Med; 2012 Dec; 154(22):64-5. PubMed ID: 23297544
    [No Abstract]   [Full Text] [Related]  

  • 9. [Essential basics in therapy of heart failure. Without diuretics the prognosis is poor].
    Bischoff A
    MMW Fortschr Med; 2002 Jul; 144(29-30):6-8. PubMed ID: 12219622
    [No Abstract]   [Full Text] [Related]  

  • 10. [Why are results of studies with digitalis so poor? "It depends on potassium!"].
    Hien M
    MMW Fortschr Med; 2003 Oct; 145(43):21. PubMed ID: 14652934
    [No Abstract]   [Full Text] [Related]  

  • 11. Prognosis assessment in patients with decompensated heart failure. Simple clinical parameters or neurohormonal factors.
    Aronson D; Burger AJ
    Ital Heart J; 2004 Jul; 5(7):494-7. PubMed ID: 15487265
    [No Abstract]   [Full Text] [Related]  

  • 12. Infusion therapy in severe heart failure. A reappraisal.
    Campana C; Scelsi L; Serio A
    Ital Heart J; 2003 May; 4 Suppl 2():15S-21S. PubMed ID: 14635365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rationale and design of the enoximone clinical trials program.
    Lowes BD; Shakar SF; Metra M; Feldman AM; Eichhorn E; Freytag JW; Gerber MJ; Liard JF; Hartman C; Gorczynski R; Evans G; Linseman JV; Stewart J; Robertson AD; Roecker EB; Demets DL; Bristow MR
    J Card Fail; 2005 Dec; 11(9):659-69. PubMed ID: 16360960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Drug therapy of heart failure. Take the chance!].
    Einecke D
    MMW Fortschr Med; 2001 Sep; 143(38):8-10, 12. PubMed ID: 11601101
    [No Abstract]   [Full Text] [Related]  

  • 15. Hawthorn extract improves chronic heart failure.
    Eaton LJ; Kinkade S
    J Fam Pract; 2003 Oct; 52(10):753-4. PubMed ID: 14529593
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pharmacological correction of impaired tolerance to strophanthin in a model of cardiac decompensation].
    Galenko-Iaroshevskiĭ PA; Lemkina SM; Kostin IaV
    Biull Eksp Biol Med; 1994 May; 117(5):487-90. PubMed ID: 9296697
    [No Abstract]   [Full Text] [Related]  

  • 17. [Is heart rate reduction beneficial to patients with heart insufficiency? Focus on beta-blockade].
    Henriksen OM; Gadsbøll N
    Ugeskr Laeger; 2002 Jan; 164(5):615-9. PubMed ID: 11871210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical use of inotropic therapy for heart failure: looking backward or forward? Part II: chronic inotropic therapy.
    Stevenson LW
    Circulation; 2003 Jul; 108(4):492-7. PubMed ID: 12885733
    [No Abstract]   [Full Text] [Related]  

  • 19. Concomitant use of a positive inotropic agent to create a bridge to the successful initiation of beta-blocker therapy in patients with heart failure: a proposal for a trial.
    Zampino M; O'Connor CM; Gattis WA; Adams KF; Gheorghiade M
    Am Heart J; 2003 Feb; 145(2 Suppl):S62-6. PubMed ID: 12594456
    [No Abstract]   [Full Text] [Related]  

  • 20. Digoxin may reduce the mortality rates in patients with congestive heart failure.
    Wang L; Song S
    Med Hypotheses; 2005; 64(1):124-6. PubMed ID: 15533628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.